FdaApplication

NDA 207501

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTELLAS PHARMA US INC
application_typeNDA
approval_date2015-03-06

Products (1)

ProductActive ingredientStrengthDosage form
CRESEMBAISAVUCONAZONIUM SULFATE372MGPOWDER;INTRAVENOUS

1 product